The same survey also found that weight loss drugs such as Ozempic and Wegovy – known as GLP-1 (glucagon-like peptide-1) drugs ...
MACE risk was associated with waist circumference reduction but not weight loss among those receiving semaglutide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback